Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • ASCI Milestone Awards
    • Video Abstracts
    • Conversations with Giants in Medicine
  • Reviews
    • View all reviews ...
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • ASCI Milestone Awards
  • Video Abstracts
  • Conversations with Giants in Medicine
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
CD8+ T cells target cerebrovasculature in children with cerebral malaria
Brittany A. Riggle, Monica Manglani, Dragan Maric, Kory R. Johnson, Myoung-Hwa Lee, Osorio Lopes Abath Neto, Terrie E. Taylor, Karl B. Seydel, Avindra Nath, Louis H. Miller, Dorian B. McGavern, Susan K. Pierce
Brittany A. Riggle, Monica Manglani, Dragan Maric, Kory R. Johnson, Myoung-Hwa Lee, Osorio Lopes Abath Neto, Terrie E. Taylor, Karl B. Seydel, Avindra Nath, Louis H. Miller, Dorian B. McGavern, Susan K. Pierce
View: Text | PDF
Clinical Research and Public Health Infectious disease Neuroscience

CD8+ T cells target cerebrovasculature in children with cerebral malaria

  • Text
  • PDF
Abstract

BACKGROUND Cerebral malaria (CM) accounts for nearly 400,000 deaths annually in African children. Current dogma suggests that CM results from infected RBC (iRBC) sequestration in the brain microvasculature and resulting sequelae. Therapies targeting these events have been unsuccessful; findings in experimental models suggest that CD8+ T cells drive disease pathogenesis. However, these data have largely been ignored because corroborating evidence in humans is lacking. This work fills a critical gap in our understanding of CM pathogenesis that is impeding development of therapeutics.METHODS Using multiplex immunohistochemistry, we characterized cerebrovascular immune cells in brain sections from 34 children who died from CM or other causes. Children were grouped by clinical diagnosis (CM+ or CM–), iRBC sequestration (Seqhi, Seqlo, Seq0) and HIV status (HIV+ or HIV–).RESULTS We identified effector CD3+CD8+ T cells engaged on the cerebrovasculature in 69% of CM+ HIV– children. The number of intravascular CD3+CD8+ T cells was influenced by CM status (CM+ > CM–, P = 0.004) and sequestration level (Seqhi > Seqlo, P = 0.010). HIV coinfection significantly increased T cell numbers (P = 0.017) and shifted cells from an intravascular (P = 0.004) to perivascular (P < 0.0001) distribution.CONCLUSION Within the studied cohort, CM is associated with cerebrovascular engagement of CD3+CD8+ T cells, which is exacerbated by HIV coinfection. Thus, CD3+CD8+ T cells are highly promising targets for CM adjunctive therapy, opening new avenues for the treatment of this deadly disease.FUNDING This research was supported by the Intramural Research Program of the National Institutes of Health.

Authors

Brittany A. Riggle, Monica Manglani, Dragan Maric, Kory R. Johnson, Myoung-Hwa Lee, Osorio Lopes Abath Neto, Terrie E. Taylor, Karl B. Seydel, Avindra Nath, Louis H. Miller, Dorian B. McGavern, Susan K. Pierce

×

Figure 6

Activated CD68+IBA1+ monocytes/macrophages in the venous cerebrovasculature.

Options: View larger image (or click on image) Download as PowerPoint
Activated CD68+IBA1+ monocytes/macrophages in the venous cerebrovasculat...
Representative images of brain sections from CM+ Seqhi HIV–, CM+ Seqlo HIV–, and CM– Seq0 HIV– (A) patients and CM+ Seqhi HIV+, CM+ Seqhi HIV–, and CM– Seq0 HIV+ (E) patients. Images show the distribution of IBA1+ (green), CD68+ (red) monocytes/macrophages in relation to CD31+ (white) cerebrovasculature and DAPI-stained cell nuclei (blue). Yellow asterisks denote the vascular lumen. Scale bars: 20 μm. Normalized counts of luminal, abluminal, and total CD68+IBA1+ inflammatory monocytes/macrophages/vessel area (log2((number of cells/μm2/104) + 2) in the same ROIs used previously are given in B–D and F–H. Each symbol represents the number of CD68+IBA1+ cells/vessel area for each of the 20 vessels examined per child. There were significantly more activated monocytes/macrophages luminally in CM+ (n = 8) versus CM– (n = 7) children (B, FDR P < 0.0001). CM+ Seqlo HIV– in B–D, n = 5. This is also reflected when comparing total cell numbers between both groups (D, FDR P < 0.030). Comparison of CM patients with (n = 8) and without (n = 8) HIV shows that CM alone promotes recruitment of activated monocytes/macrophages on the luminal aspect of cerebrovasculature (F, FDR P < 0.006). This observation is also evident when comparing CM+ Seqhi HIV– and CM– Seq0 HIV+ (n = 4) patients (F, FDR P < 0.002). P values were obtained via post hoc analysis using the difflsmeans function under FDR correction conditions following mixed-effects modeling with the lmer function. Significant differences remained so under bootstrap conditions 100% of the time when any single vessel normalized cell count was removed or when all vessels for any 1 child were removed. Error bars: mean ± SD. Asterisks denote statistical significance: FDR *P ≤ 0.05; **P ≤ 0.01; ****P < 0.0001.

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts